{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:12:41Z","timestamp":1777417961540,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jceh.2014.12.010","type":"journal-article","created":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T19:48:24Z","timestamp":1421437704000},"page":"14-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Study of the Effects of Cyclooxygenase-2 Inhibitor on the Promotion of Hepatic Tumorigenesis in Rats Fed a High Fat Diet"],"prefix":"10.1016","volume":"5","author":[{"given":"Magda","family":"Hamzawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila","family":"Elsaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa","family":"Shams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soheir","family":"Mahfouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nivin","family":"Sharawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2014.12.010_bib1","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/liv.12209","article-title":"Epidemiological characteristics of hepatocellular carcinoma in Egypt: a retrospective analysis of 1313 cases","volume":"33","author":"Shaker","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2014.12.010_bib2","first-page":"5016","article-title":"Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition?","volume":"61","author":"Yang","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.jceh.2014.12.010_bib3","first-page":"511","article-title":"Biological & physiological aspects of action of insulin-like growth factor peptide family","volume":"125","author":"Pavelic","year":"2007","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jceh.2014.12.010_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10549-007-9763-9","article-title":"Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance","volume":"111","author":"Knowlden","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jceh.2014.12.010_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2049-3002-1-10","article-title":"Calorie restriction and cancer prevention: a mechanistic perspective","volume":"1","author":"Hursting","year":"2013","journal-title":"Cancer Metab"},{"key":"10.1016\/j.jceh.2014.12.010_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-4615-0193-0_28","article-title":"Cyclooxygenase-2 in human pathological disease","volume":"507","author":"Koki","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jceh.2014.12.010_bib7","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3748\/wjg.v8.i5.815","article-title":"Significance of cyclooxygenase-2 expression in human primary hepatocellular carcinoma","volume":"8","author":"Qiu","year":"2002","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2014.12.010_bib8","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.3748\/wjg.v12.i32.5113","article-title":"Cyclooxygenases in hepatocellular carcinoma","volume":"12","author":"Cervello","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2014.12.010_bib9","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.3748\/wjg.v11.i30.4638","article-title":"Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: possible role in tumor promotion and angiogenesis","volume":"11","author":"Cervello","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2014.12.010_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1474-9726.2008.00417.x","article-title":"Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans","volume":"7","author":"Fontana","year":"2008","journal-title":"Aging Cell"},{"key":"10.1016\/j.jceh.2014.12.010_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1200\/JOP.2010.000040","article-title":"A\u00a0patient's perspective on the multidisciplinary liver\/pancreas tumor clinic: an all-in-one resort","volume":"6","author":"Gantos-O'Brien","year":"2010","journal-title":"J\u00a0Oncol Pract"},{"key":"10.1016\/j.jceh.2014.12.010_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1743-7075-8-28","article-title":"Impact of chromium histidinate on high fat diet induced obesity in rats","volume":"8","author":"Tuzcu","year":"2011","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.jceh.2014.12.010_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1756-9966-30-49","article-title":"Efficacy of mesenchymal stem cells in suppression of hepatocarcinorigenesis in rats: possible role of Wnt signaling","volume":"30","author":"Abdel aziz","year":"2011","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.jceh.2014.12.010_bib14","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1093\/hmg\/ddp236","article-title":"Diet-induced hepatocellular carcinoma in genetically predisposed mice","volume":"18","author":"Hill-Baskin","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jceh.2014.12.010_bib15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0028-1091981","article-title":"Mechanisms of disease progression in nonalcoholic fatty liver disease","volume":"28","author":"Jou","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2014.12.010_bib16","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.expneurol.2004.10.011","article-title":"High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex","volume":"191","author":"Zhang","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jceh.2014.12.010_bib17","first-page":"215158","article-title":"The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies","author":"Sobolewski","year":"2010","journal-title":"Int J Cell Biol"},{"key":"10.1016\/j.jceh.2014.12.010_bib18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3349\/ymj.2007.48.3.495","article-title":"Expression of cyclooxygenase-2 and its relationship to p53 accumulation in colorectal cancers","volume":"48","author":"Lim","year":"2007","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jceh.2014.12.010_bib19","first-page":"1913","article-title":"Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenocarcinoma cells","volume":"177","author":"Anai","year":"2007","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jceh.2014.12.010_bib20","first-page":"503","article-title":"Cyclooxygenase-2 gene expression in human breast cancer","volume":"10","author":"Parrett","year":"1997","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jceh.2014.12.010_bib21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/qjmed\/hci119","article-title":"COX and cancer","volume":"98","author":"Mazhar","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.jceh.2014.12.010_bib22","first-page":"3796","article-title":"Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer","volume":"8","author":"Chang","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jceh.2014.12.010_bib23","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1038\/sj.onc.1204561","article-title":"Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis","volume":"20","author":"Kozaki","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.jceh.2014.12.010_bib24","first-page":"6726","article-title":"Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway","volume":"63","author":"Yasumaru","year":"2003","journal-title":"Cancer Res"},{"issue":"4 Pt 2","key":"10.1016\/j.jceh.2014.12.010_bib25","first-page":"F673","article-title":"IGF-I and insulin amplify IL-1 beta-induced nitric oxide and prostaglandin biosynthesis","volume":"274","author":"Guan","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jceh.2014.12.010_bib26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1756-8722-4-30","article-title":"Targeting insulin-like growth factor axis in hepatocellular carcinoma","volume":"4","author":"Wu","year":"2014","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.jceh.2014.12.010_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3835(03)00159-9","article-title":"The insulin-like growth factor system and cancer","volume":"195","author":"LeRoith","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jceh.2014.12.010_bib28","first-page":"80","article-title":"Nutritional regulation of the insulin-like growth factors","volume":"15","author":"Thissen","year":"1994","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jceh.2014.12.010_bib29","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/jnci\/91.7.620","article-title":"Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3","volume":"91","author":"Ma","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jceh.2014.12.010_bib30","first-page":"852","article-title":"Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations","volume":"11","author":"Holmes","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6 suppl l","key":"10.1016\/j.jceh.2014.12.010_bib31","doi-asserted-by":"crossref","first-page":"1557S","DOI":"10.1093\/ajcn\/66.6.1557S","article-title":"Specific fatty acids and risks of breast and prostate cancer: dietary intake","volume":"66","author":"Willett","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jceh.2014.12.010_bib32","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.coph.2008.07.004","article-title":"Targeting insulin and insulin-like growth factor signalling in oncology","volume":"8","author":"Pollak","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jceh.2014.12.010_bib33","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4158\/EP10098.RA","article-title":"The pathway from diabetes and obesity to cancer, on the route to targeted therapy","volume":"16","author":"Gallagher","year":"2010","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jceh.2014.12.010_bib34","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1073\/pnas.81.3.935","article-title":"Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action","volume":"81","author":"D'Ercole","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jceh.2014.12.010_bib35","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1158\/0008-5472.CAN-04-1225","article-title":"Cyclooxygenase-2 modulates the insulin-like growth factor axis in non-small-cell lung cancer","volume":"64","author":"Pold","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.jceh.2014.12.010_bib36","doi-asserted-by":"crossref","first-page":"e46851","DOI":"10.1371\/journal.pone.0046851","article-title":"Development of IGF signaling antibody arrays for the identification of hepatocellular carcinoma biomarkers","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2014.12.010_bib37","first-page":"12","article-title":"Characterization of insulin-like-growth factor II (IGF II) mRNA positive hepatic altered foci and IGF II expression in hepatocellular carcinoma during diethylnitrosamine-induced hepatocarcinogenesis in rats","volume":"4","author":"Mukherjee","year":"2005","journal-title":"J\u00a0Carcinog"},{"key":"10.1016\/j.jceh.2014.12.010_bib38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2613.2009.00656.x","article-title":"Experimental mouse models for hepatocellular carcinoma research","volume":"90","author":"Heindryckx","year":"2009","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.jceh.2014.12.010_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.toxlet.2012.06.014","article-title":"High-fat diet causes an imbalance in the colonic serotonergic system promoting adipose tissue enlargement and dysplasia in rats","volume":"213","author":"Kannen","year":"2012","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.jceh.2014.12.010_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0304-3835(02)00201-X","article-title":"Cyclooxygenase-2 inhibitor celecoxib inhibits promotion of mammary tumorigenesis in rats fed a high fat diet rich in n-6 polyunsaturated fatty acids","volume":"184","author":"Lu","year":"2002","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jceh.2014.12.010_bib41","first-page":"643","article-title":"Celecoxib decreases fatty acid synthase expression via down-regulation of c-Jun N-terminal kinase-1","volume":"232","author":"Lu","year":"2007","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.jceh.2014.12.010_bib42","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/carcin\/bgh110","article-title":"Cyclooxygenase-2 inhibitors suppress the growth of human hepatocellular carcinoma implants in nude mice","volume":"25","author":"Kern","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jceh.2014.12.010_bib43","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/cyto.2001.1008","article-title":"Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-2OS human osteosarcoma cells","volume":"17","author":"Duan","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.jceh.2014.12.010_bib44","first-page":"58","article-title":"Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer","volume":"1","author":"Johnson","year":"2012","journal-title":"Transl Gastrointest Cancer"},{"key":"10.1016\/j.jceh.2014.12.010_bib45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/omi.2010.0093","article-title":"IL-6 -174G\/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma","volume":"15","author":"Giannitrapani","year":"2011","journal-title":"OMICS"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688315000080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688315000080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:02:02Z","timestamp":1760853722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688315000080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0973688315000080"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2014.12.010","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study of the Effects of Cyclooxygenase-2 Inhibitor on the Promotion of Hepatic Tumorigenesis in Rats Fed a High Fat Diet","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2014.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 INASL. Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}